EUVIMEDEUVIMED entdecken
Crossref

Pregnancy Outcomes in Patients with Type 1 Diabetes Using Continuous Glucose Monitoring

Shannon M McCloskey iD, Joseph R Biggio, John A Morgan, Naiha Mussarat, James D Toppin, Sarah J Sternlieb, Nicholas E Manuel, Kali Juracek, Sharon W Shu, Jesse Stone, Frank B Williams iD

American Journal of Perinatology · 2026-08 · 43 (11) · 1419-1426

DOI: 10.1055/a-2781-7373 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Perinatology, online erschienen am 22.01.2026. Verfasst von Shannon M McCloskey und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Maternal-Fetal Medicine, Ochsner Health, New Orleans, Louisiana, United States. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Continuous Glucose Monitoring, Pregnancy Outcome, Pregnancy in Diabetics. Die Arbeit nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Continuous glucose monitoring (CGM) use among patients with type 1 diabetes mellitus (T1DM) has been associated with improved glycemic control, though improvement in non-glycemic outcomes is less consistent. We hypothesize that CGM use in patients with T1DM in a real-world clinical setting is associated with both improved glycemic and clinical outcomes. This was a retrospective cohort study of patients with T1DM receiving care at a large health system from 2016 to 2023. Primary outcomes included (1) glycemic control and (2) a composite comprising severe maternal morbidity, preeclampsia with severe features, delivery prior to 34 weeks, and admission for diabetic ketoacidosis. Primary glycemic outcome was hemoglobin A1c (HbA1c)

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 1Continuous Glucose MonitoringPregnancy OutcomePregnancy in DiabeticsHumansFemalePregnancyRetrospective StudiesGlycated HemoglobinAdultBlood GlucoseGlycemic ControlPre-EclampsiaDiabetic KetoacidosisBlood Glucose Self-Monitoring

Substanzen

Glycated HemoglobinBlood Glucose

Autor:innen und Institutionen

  • Department of Maternal-Fetal Medicine, Ochsner Health, New Orleans, Louisiana, United States.
  • Department of Endocrinology, Ochsner Health, New Orleans, Louisiana, United States.
  • Ochsner Clinical School, University of Queensland Medical School, New Orleans, Louisiana.

ORCID-Profile: Shannon M McCloskey, Frank B Williams

Zitieren

APA

McCloskey, S. M., Biggio, J. R., Morgan, J. A., Mussarat, N., Toppin, J. D., Sternlieb, S. J., Manuel, N. E., Juracek, K., Shu, S. W., Stone, J., & Williams, F. B. (2026). Pregnancy Outcomes in Patients with Type 1 Diabetes Using Continuous Glucose Monitoring. American Journal of Perinatology, 43(11), 1419-1426. https://doi.org/10.1055/a-2781-7373

Vancouver

McCloskey SM, Biggio JR, Morgan JA, Mussarat N, Toppin JD, Sternlieb SJ, et al. Pregnancy Outcomes in Patients with Type 1 Diabetes Using Continuous Glucose Monitoring. American Journal of Perinatology. 2026;43(11):1419-1426. doi:10.1055/a-2781-7373

BibTeX
@article{McCloskey2026,
  author = {McCloskey, Shannon M and Biggio, Joseph R and Morgan, John A and Mussarat, Naiha and Toppin, James D and Sternlieb, Sarah J and Manuel, Nicholas E and Juracek, Kali and Shu, Sharon W and Stone, Jesse and Williams, Frank B},
  title = {Pregnancy Outcomes in Patients with Type 1 Diabetes Using Continuous Glucose Monitoring},
  journal = {American Journal of Perinatology},
  year = {2026},
  volume = {43},
  number = {11},
  pages = {1419--1426},
  doi = {10.1055/a-2781-7373}
}
Kostenlos starten →